This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Prevention of Illness in Man by Aerosolized Inactivated Vaccine

Robert H. Waldman, MD; John J. Mann, MD; Parker A. Small, Jr., MD

JAMA. 1969;207(3):520-524.

Abstract
During the A2 influenza epidemic of the winter of 1967 to 1968, commercially available inactivated influenza virus vaccine, bivalent, was administered by aerosol to 386 volunteers to test its efficacy in protecting against influenza illness. The illness rate in volunteers receiving the aerosolized vaccine was compared to that of 269 persons receiving the same vaccine subcutaneously and to that of 1,490 persons who received either sodium chloride solution or no inoculation. The group receiving aerosolized influenza vaccine had 79% fewer illnesses while subcutaneously immunized volunteers had 27% fewer illnesses, when compared to the control groups receiving no immunization. In addition to its superiority in ability to protect against naturally occurring influenza illness, the aerosolized vaccine led to a significantly lower incidence of side effects and to a significantly shorter duration of illness in those few who became ill.

Author Affiliations
From the Department of Medicine, Division of Infectious Diseases, University of Florida, Gainesville (Drs. Waldman and Small); and the Department of Medicine, Johns Hopkins Medical School, Baltimore (Dr. Mann).

Footnotes
Read in part before the Infectious Disease Section of the American Federation for Clinical Research, Atlantic City, NJ, May 5, 1968.

Reprint requests to Department of Medicine, Division of Infectious Diseases, University of Florida, Gainesville, Fla 32601 (Dr. Waldman).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Vaccination against Influenza in Healthy Adults
Small et al.
NEJM 1996;334:402-404.
FULL TEXT  

Failure of Inactivated Influenza Vaccine to Protect an Aged Population
D'Alessio et al.
JAMA 1969;210:485-489.
ABSTRACT  

Human Influenza: Aspects of the Immune Response to Vaccination
KASEL et al.
ANN INTERN MED 1969;71:369-398.
ABSTRACT